Acceptability and Tolerance Study of New Oral Nutritional Supplement PRAGUE
NCT02831647 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2020-01-09
Summary
Tolerance and Acceptability of new oral nutritional supplement - AYMES PRAGUE
Conditions
- Malnutrition
Interventions
- DIETARY_SUPPLEMENT
-
AYMES PRAGUE
AYMES PRAGUE is a ready to drink, high energy, low volume oral nutritional supplement drink. It provides 300 kcal and 12g protein per 125ml serving. It is a Food for Special Medical Purposes (FSMP) and must therefore be used under medical supervision. It is not designed as a sole source of nutrition.
Sponsors & Collaborators
-
Eat Well Now
collaborator UNKNOWN -
Aymes International Limited
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-01
- Primary Completion
- 2016-12-01
- Completion
- 2016-12-01
More Related Trials
-
Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease
NCT00250146 ·Status: TERMINATED ·Phase: NA
-
Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease
NCT00492960 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects
NCT00362856 ·Status: COMPLETED ·Phase: PHASE2
-
Bread Study: Comparison of the Tolerance of Spelt and Wheat Bread
NCT04401956 ·Status: COMPLETED ·Phase: NA
-
Food Oral Immunotherapy for Peanut Allergy
NCT04222491 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease
NCT00889473 ·Status: COMPLETED ·Phase: PHASE2
-
Wheat Bread Study: Comparison of the Tolerance of Different Wheat Breads
NCT06152445 ·Status: RECRUITING ·Phase: NA
-
Safety Study of Larazotide Acetate to Treat Celiac Disease.
NCT00386165 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease
NCT03707730 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease
NCT02637141 ·Status: COMPLETED ·Phase: PHASE2
-
Gastrointestinal Tolerance Assessment of T2309
NCT04596605 ·Status: COMPLETED ·Phase: NA
-
Childrens Real Food Tolerance Study
NCT05269992 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
NICE - Nutritional Impact on Immunological Maturation During Childhood in Relation to the Environment
NCT05809479 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Effect of Lactisole on the Intestinal Glucose Uptake
NCT00631293 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prevention of Celiac Disease in Skåne
NCT03562221 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study
NCT02198664 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet
NCT04530123 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Tolerance to Oral Peanut
NCT01259804 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic Patients
NCT02960074 ·Status: COMPLETED ·Phase: PHASE1
-
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
NCT01396213 ·Status: COMPLETED ·Phase: PHASE2
-
Gluten Sensibility in Elite Athletes
NCT03101410 ·Status: COMPLETED ·Phase: NA
-
Changes in Intestinal Permeability 4 Hours After Gluten Challenge
NCT03288831 ·Status: COMPLETED ·Phase: NA
-
Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Healthy Subjects
NCT03798262 ·Status: COMPLETED ·Phase: NA
-
Celiac Disease Prevention With Probiotics
NCT03176095 ·Status: COMPLETED ·Phase: NA
-
Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease
NCT02220166 ·Status: COMPLETED ·Phase: PHASE2